Description
Description: Imbruvica contains ibrutinib, a Bruton’s tyrosine kinase inhibitor used to treat specific types of blood cancers.
Contents: Each capsule contains 140mg of ibrutinib.
Uses:
- Treatment of chronic lymphocytic leukemia (CLL).
- Treatment of mantle cell lymphoma (MCL).
How it Works: Inhibits Bruton’s tyrosine kinase, disrupting signals that promote cancer cell survival and proliferation.
Directions for Use: Taken orally once daily, with or without food.
Side Effects:
- Diarrhea
- Fatigue
- Nausea
- Risk of bleeding
Precautions: Regular monitoring of blood counts is necessary. Not recommended during pregnancy or breastfeeding due to potential risks to the fetus or infant.
There are no reviews yet.